Product
Help
Pricing
About
Jobs
Log in
Get started
Work
Add to collection
Recent Advances in Selective and Irreversible Covalent Ligand Development and Validation
HTML
PDF
Details
Locations
Year:
2019
Type:
review
Source:
Cell chemical biology
DOI:
10.1016/j.chembiol.2019.09.012
Authors:
Tinghu Zhang,
John M. Hatcher,
Mingxing Teng,
Nathanael S. Gray,
Milka Kostic
Institutions:
Harvard University,
Dana-Farber Cancer Institute,
Dana-Farber/Harvard Cancer Center
Language:
English
Topic:
Click Chemistry and Applications
Subfield:
Organic Chemistry
Field:
Chemistry
Domain:
Physical Sciences
SDG:
Good health and well-being
Open Access status:
bronze
Funders:
Astellas Pharma US,
Novartis,
Sanofi,
Taiho Pharmaceutical,
National Institutes of Health,
National Cancer Institute,
Janssen Pharmaceuticals
show all 7
Award:
Targeting ALK through Degradation and Allosteric Inhibitors
OpenAlex ID:
W2980410567
FWCI:
1.61
Cites:
88
Cited by:
178
Related to:
10